Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan.
Saved in:
| Title: | Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan. |
|---|---|
| Authors: | Valsecchi AA; Department of Oncology, University of Turin, A.O.U. Città della Salute e della Scienza di Torino, Ospedale Molinette, Turin, Italy., Pisegna S; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.; Medical Oncology Unit, Sant'Andrea Hospital of Rome, Rome, Italy., Antonuzzo A; Internistic and Geriatric Supportive Care, Fondazione IRCCS - National Cancer Institute, Milan, Italy., Arpino G; Oncology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy., Bianchini G; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milano, Italy.; School of Medicine, Vita-Salute San Raffaele University, Milano, Italy., Biganzoli L; Department of Oncology, Hospital of Prato, Azienda USL Toscana Centro, Italy., Colloca GF; Department of Imaging Diagnostic, Oncologic Radiotherapy and Haematology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Criscitiello C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hematology-Oncology (DIPO), University of Milan, Milan, Italy., Danesi R; Department of Oncology and Hemato-Oncology, University of Milano 'La Statale,' Milan, Italy., Fabi A; Precision Medicine Unit in Senology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Giusti R; Medical Oncology Unit, Sant'Andrea Hospital, Rome, Italy., Pau L; Europa Donna Italia, Milan, Italy., Di Maio M; Department of Oncology, University of Turin, A.O.U. Città della Salute e della Scienza di Torino, Ospedale Molinette, Turin, Italy., Santini D; Medical-Surgical Sciences and Biotechnology, La Sapienza University of Rome, Rome, Italy.; Medical Oncology A, Policlinico Umberto 1, Rome, Italy. |
| Source: | The oncologist [Oncologist] 2025 May 08; Vol. 30 (5). |
| Publication Type: | Journal Article; Consensus Statement |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1549-490X |
|---|---|
| DOI: | 10.1093/oncolo/oyaf088 |
